175 related articles for article (PubMed ID: 15052815)
1. [Etiology of and therapy for type-2 diabetes mellitus].
Kazuga M
Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):527-31. PubMed ID: 15052815
[No Abstract] [Full Text] [Related]
2. [Therapies for newly-onset diabetic patients].
Kawamori R
Nihon Rinsho; 2005 Feb; 63 Suppl 2():525-32. PubMed ID: 15779435
[No Abstract] [Full Text] [Related]
3. Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
Szoke E; Gerich JE
Compr Ther; 2005; 31(2):106-12. PubMed ID: 15901939
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of type 2 diabetes and its relationship to new therapeutic approaches.
Bell D
Diabetes Educ; 2000; 26 Suppl():4-7. PubMed ID: 11912815
[No Abstract] [Full Text] [Related]
5. [Type 2 diabetes mellitus].
Kashiwagi A
Nihon Rinsho; 2006 Sep; Suppl 3():42-8. PubMed ID: 17022497
[No Abstract] [Full Text] [Related]
6. [Etiopathogenesis, physiopathology and general principles of therapy of type II diabetes].
Scheen A; Lefèbvre PJ
Rev Med Liege; 1988 Apr; 43(7):205-11. PubMed ID: 3287543
[No Abstract] [Full Text] [Related]
7. Focus on insulin resistance in type 2 diabetes: therapeutic implications.
Reusch JE
Diabetes Educ; 1998; 24(2):188-93. PubMed ID: 9555358
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenic mechanism of type 2 diabetes mellitus from impaired glucose tolerance/borderline type and its reversibility].
Yoshimoto K; Ozawa S; Ishida H
Nihon Rinsho; 2005 Feb; 63 Suppl 2():95-9. PubMed ID: 15779352
[No Abstract] [Full Text] [Related]
9. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
Evans AJ; Krentz AJ
Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
[No Abstract] [Full Text] [Related]
10. [Modern methods of correction of systemic inflammation and insulin resistance by patients with coronary heart disease and diabetes mellitus type 2].
Rasin MS; Shaenko ZA
Lik Sprava; 2014; (3-4):60-5. PubMed ID: 25286600
[TBL] [Abstract][Full Text] [Related]
11. A 64-year-old man with adult-onset diabetes.
Rubenstein AH
JAMA; 1996 Sep; 276(10):816-22. PubMed ID: 8769592
[No Abstract] [Full Text] [Related]
12. Type 2 diabetes mellitus in youth: the complete picture to date.
Gungor N; Hannon T; Libman I; Bacha F; Arslanian S
Pediatr Clin North Am; 2005 Dec; 52(6):1579-609. PubMed ID: 16301084
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of type 2 diabetes: implications for metformin.
DeFronzo RA
Drugs; 1999; 58 Suppl 1():29-30; discussion 75-82. PubMed ID: 10576522
[No Abstract] [Full Text] [Related]
14. What comes after metformin for type 2 diabetes.
Med Lett Drugs Ther; 2012 Jul; 54(1395):58-9. PubMed ID: 22825689
[No Abstract] [Full Text] [Related]
15. [Initial therapy of diabetes mellitus in the family practice. Give yourself time!].
MMW Fortschr Med; 2008 Oct; 150(42):25. PubMed ID: 18985907
[No Abstract] [Full Text] [Related]
16. [Guideliness for drug treatment of type 2 diabetes mellitus].
Ann Endocrinol (Paris); 2000 May; 61(2):168-73. PubMed ID: 10891670
[No Abstract] [Full Text] [Related]
17. [Diabetes, sport and exercise].
Fischer H
Clin Res Cardiol Suppl; 2011 May; 6():6-9. PubMed ID: 22528172
[TBL] [Abstract][Full Text] [Related]
18. [Non-insulin-dependent diabetes: from physiopathology to treatment].
Scheen AJ; Lefebvre PJ
Bull Mem Acad R Med Belg; 1996; 151(7-9):395-402; discussion 402-5. PubMed ID: 9221054
[TBL] [Abstract][Full Text] [Related]
19. Type II diabetes mellitus.
Edelman SV
Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
[TBL] [Abstract][Full Text] [Related]
20. [Hypoglycemic therapy in heart disease patients with type 2 diabetes mellitus].
Cosmi F; Cosmi D
G Ital Cardiol (Rome); 2010 Jun; 11(6):460-6. PubMed ID: 20922871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
